Vile RG - Search Results

1

Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.

Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG. Bateman A, et al. Among authors: vile rg. Cancer Res. 2000 Mar 15;60(6):1492-7. Cancer Res. 2000. PMID: 10749110

2

Gene transfer technologies for the gene therapy of cancer.

Vile R, Russell SJ. Vile R, et al. Gene Ther. 1994 Mar;1(2):88-98. Gene Ther. 1994. PMID: 7584073 Review.

3

Retroviruses as vectors.

Vile RG, Russell SJ. Vile RG, et al. Br Med Bull. 1995 Jan;51(1):12-30. doi: 10.1093/oxfordjournals.bmb.a072941. Br Med Bull. 1995. PMID: 7767638 Review.

4

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.

Vile RG, Nelson JA, Castleden S, Chong H, Hart IR. Vile RG, et al. Cancer Res. 1994 Dec 1;54(23):6228-34. Cancer Res. 1994. PMID: 7954471

5

Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.

Vile RG, Hart IR. Vile RG, et al. Cancer Res. 1993 Sep 1;53(17):3860-4. Cancer Res. 1993. PMID: 8395331

6

Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.

Vile RG, Diaz RM, Miller N, Mitchell S, Tuszyanski A, Russell SJ. Vile RG, et al. Virology. 1995 Dec 1;214(1):307-13. doi: 10.1006/viro.1995.9923. Virology. 1995. PMID: 8525635 Free article.

7

Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.

Melcher A, Todryk S, Bateman A, Chong H, Lemoine NR, Vile RG. Melcher A, et al. Among authors: vile rg. Cancer Res. 1999 Jun 15;59(12):2802-5. Cancer Res. 1999. PMID: 10383135

8

Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectors.

Melcher A, Murphy S, Vile R. Melcher A, et al. Hum Gene Ther. 1999 Jun 10;10(9):1431-42. doi: 10.1089/10430349950017770. Hum Gene Ther. 1999. PMID: 10395369

9

Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG. Todryk S, et al. Among authors: vile rg. J Immunol. 1999 Aug 1;163(3):1398-408. J Immunol. 1999. PMID: 10415040

10

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors.

Peng KW, Vile R, Cosset FL, Russell S. Peng KW, et al. Gene Ther. 1999 Sep;6(9):1552-7. doi: 10.1038/sj.gt.3300982. Gene Ther. 1999. PMID: 10490764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters